Dr. Unger is Professor of Radiology and Biomedical Engineering at the University of Arizona. He received his medical degree from University of California at San Francisco School of Medicine. He completed his early training in Radiology at Mallinckrodt Institute of Radiology in St. Louis, MO. He has been an innovator in a number of fields and is inventor on more than 112 issued US patents. He has extensive experience in clinical translation. Research SupportPrincipal Investigator, NIH STTR, 1R41NS057860-01A-1, Targeted Blood Brain Barrier Permeability Changes with Ultrasound and Microbubbles, $949,596.00 in total funding, Sept. 1st 2007 to August 31st, 2009.PI of subcontract, NIH I Rol EBoo9o50-oi, Ultrasound and Targeted Microbubbles to Treat Myocardial Infarction, PI Xie, $201,600 in funding to my lab in sub-contract 2008 to 2013. My lab makes non-targeted bubbles and bubbles targeted to GPIIBIIIA and to fibrin for the project.Co-investigator, "Microbubble Enhanced FUS for More Efficient Therapy of Uterine Fibroids," $102,324.00 received from FUS Foundation, April 2009 to April 2010.Principal Investigator, "Development of Novel Sensitizer to Improve Response of Hypoxic Tumors to Radiation," 1R43CA144817-oi, $204,000, 7/01/2010 to 12/31/2010.Program Co-Leader, Arizona Cancer Center Imaging Program, NCI P50, January 2010 to present provides about io% of my salary support from NCI.Co-investigator, "Biological nanocomposites (BNC) to diagnose diabetic pre-retinopathy." QTDP program, stimulus funds from federal government through IRS. $488,000.00, July 1st 2010 to December 31st, 2010. My lab does the bulk of the work on this project preparing the nanoparticles and targeting ligands for theranostic targeted to e-Selectin in diabetic pre-retinopathy.
The Tucson Myofilament Meeting is an international 3.5-day Sarver Heart Center conference that brings together approximately 250 scientists focused on the structure and function of the myofilaments that comprise the contractile machinery of muscle. Spanning topics from molecular biophysics to heart and skeletal muscle disease mechanisms and drug development, the meeting is known for its highly interactive, collaborative, and informal atmosphere, with strong engagement of early career investigators.
Traditionally held biennially at the University of Wisconsin, the meeting will continue at the University of Arizona beginning in May 2026, offering a distinctive Tucson setting that fosters scientific exchange and community building.